Security key
G1146Y101
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 44,600
- Total 13F value
- $627,037
- Share change
- +44,600
- SEC-reported price per share
- $14.06
- Number of holders
- 1
- Value change
- +$627,037
- Number of buys
- 1
- Shares outstanding
- 1,552,649,190
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
1
Top holders
1
G1146Y101 full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
BeOne Medicines Ltd. SEC filings
BeOne Medicines Ltd. company facts
BeOne Medicines Ltd. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP G1146Y101
Recent filing periods:
Ownership snapshot
Top reported holders of G1146Y101 - BeOne Medicines Ltd. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HHLR ADVISORS, LTD.
Disclosed value leader
HHLR ADVISORS, LTD.
Comparable rows
0/15
Latest evidence
02 Dec 2024
3/4/5
13F
Highest disclosed value: $25,009,148,200
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
HHLR ADVISORS, LTD. has the largest disclosed position value at $25.01B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HHLR ADVISORS, LTD.'s linked filing trail.
Disclosed position value
Top 5
HHLR ADVISORS, LTD.
$25.01B
AMGEN INC
$3.42B
BAKER BROS. ADVISORS LP
$2.37B
Capital International Investors
$1.44B
PRIMECAP MANAGEMENT CO/CA/
$1.12B
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
3/4/5
13F
10%+ Owner · Company
|
—
denominator unverified
|
$25,009,148,200
125,045,741 shares
|
— | 02 Dec 2024 |
| AMGEN INC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$3,419,356,261
18,943,802 shares
|
— | 10 Sep 2021 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$2,372,823,065
10,568,897 shares
|
— | 30 Sep 2024 |
| Capital International Investors |
13F
Company
|
—
denominator unverified
|
$1,441,427,971
6,430,884 shares
|
— | 30 Sep 2024 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
—
denominator unverified
|
$1,116,777,627
4,974,289 shares
|
— | 30 Sep 2024 |
| BAILLIE GIFFORD & CO |
13F
Company
|
—
denominator unverified
|
$831,979,279
3,705,756 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
44,600
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
0
Q4 2024 holders
1
Holder diff
1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend